Osirium Technologies PLC Contract win with major regional NHS Trust (5144D)
February 20 2020 - 1:00AM
UK Regulatory
TIDMOSI
RNS Number : 5144D
Osirium Technologies PLC
20 February 2020
20 February 2020
RNS REACH
Osirium Technologies plc
("Osirium" or "Group")
Contract win with major regional NHS Trust
Osirium Technologies plc (AIM: OSI.L), a leading vendor of
cloud-based cybersecurity software, is pleased to announce a
contract win with one of the UK's largest regional NHS Trusts.
The new client has purchased a 36 month term license for 500
devices, with Osirium delivering its PxM Platform including the
Privileged Access Management, Privileged Task Management and
Privileged Session Management modules .
The PxM platform has been selected in a public sector tender bid
against competing bids from two other Privileged Access Management
solution providers to minimise the risk of security breaches in a
mixed Windows and Cisco environment. Drivers for the implementation
include securing and controlling access to the infrastructure by
the 3(rd) party contractors, vendors and service providers on whom
the Trust depends. The platform is also being used to enhance
security by controlling and reducing the number of privileged
accounts accessed by internal staff.
David Guyatt, Chief Executive Officer, commented : "This brings
another NHS Trust into our client roster and shows that Osirium is
increasingly recognised as the PAM specialist best able to help
these organisations address the security challenges they face. We
see this as a further illustration of how NHS customers see us as
strategic partners in strengthening the security of their IT
operations."
- Ends -
For further information:
Osirium Technologies plc Tel: +44 (0) 118 324 2444
David Guyatt, Chief Executive Officer
Rupert Hutton, Chief Financial
Officer
www.osirium.com
Stifel Nicolaus Europe Limited Tel: +44 (0) 20 7710 7600
(Nominated Adviser and Broker)
Fred Walsh / Neil Shah
Alma
(Financial PR)
Hilary Buchanan / Josh Royston Tel: +44 (0) 203 405 0205
/ Kieran Breheny
Notes to Editors:
Osirium Technologies plc (AIM: OSI) operates in one of the
fastest growing parts of the cybersecurity market and is a leading
vendor of Privileged Access Security solutions. Osirium's
cloud-based products protect critical IT assets, infrastructure and
devices by preventing targeted cyber-attacks from directly
accessing Privileged Accounts, removing unnecessary access and
powers of Privileged Account users, deterring legitimate Privileged
Account users from abusing their roles and containing the effects
of a breach if one does happen.
Osirium has defined and delivered what the Directors view as the
next generation Privileged Access Management solution. Osirium's
award-winning Privileged Task Management module further strengthens
Privileged Account Security by minimising the cyber-attack surface
and delivering an impressive return on investment benefits for
customers. Building on Osirium's Privileged Task Management module,
in May 2019 Osirium launched Privileged Process Automation,
providing a highly-flexible platform for automating essential IT
processes to set a new benchmark in IT Process Automation. This was
followed by the launch of Privileged Endpoint Manager in December
2019, bringing the total portfolio to three complementary
solutions.
Founded in 2008 and with its headquarters in Reading, UK, the
Group was admitted to AIM in April 2016. For further information
please visit www.osirium.com.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NRAKKCBPPBKDOBD
(END) Dow Jones Newswires
February 20, 2020 02:00 ET (07:00 GMT)
Osirium Technologies (LSE:OSI)
Historical Stock Chart
From Apr 2024 to May 2024
Osirium Technologies (LSE:OSI)
Historical Stock Chart
From May 2023 to May 2024